As one of the fastest growing life sciences ecosystems, Houston’s world-class medical centers, research institutions and private companies are positioned to take on the greatest medical challenges of our generation.
Join Us!
Join us at Booth #4700! June 22-25, 2026
Learn More
Houston is one of the top destinations in the world for health, life sciences, and translational research, with $1 billion in annual research investment. Houston offers leading companies access to the youngest, fastest growing, and most diverse workforces in the country, powered by strategic upskilling and academic collaborations.
(2020 - 2025)
Just months after announcing a $6.5 billion investment in Houston, pharmaceutical giant Eli Lilly is doubling down on the region with the acquisition of local biotech startup CrossBridge Bio. Founded in 2023, CrossBridge Bio is developing targeted cancer therapies known as antibody-drug conjugates, or ADCs, created by researchers at UTHealth Houston.
All eyes are on the Houston region’s life sciences and biotechnology ecosystem. With the recent $6.5 billion manufacturing announcement from Eli Lilly, the launch of San Jacinto College’s Center for Biotechnology, and hosting a delegation from the National Security Commission on Emerging Biotechnology (NSCEB) – it’s clear there is growing momentum surrounding Houston’s biotech industry.
Houston is globally recognized as a powerhouse in healthcare but that’s only part of the story. Today, the region is rapidly emerging as a leader in medical technology, building on decades of innovation to drive the next generation of companies, high-quality jobs, and breakthrough solutions. Houston’s MedTech momentum isn’t new, it’s the natural evolution of a legacy that continues to scale, attract investment and shape the future of health.
News | September 23, 2025
Houston Wins Texas' First Major Pharma Plant With $6.5B Investment
Eli Lilly and Company, one of the world’s largest pharmaceutical manufacturers, will invest $6.5 billion to build a 236-acre manufacturing facility at Generation Park in Houston. The project marks the first major pharmaceutical manufacturing facility investment in Texas and is expected to create more than 615 full-time jobs.
